Market revenue in 2023 | USD 17.8 million |
Market revenue in 2030 | USD 34.5 million |
Growth rate | 10% (CAGR from 2023 to 2030) |
Largest segment | Dual channel |
Fastest growing segment | Single Channel |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Single Channel, Dual Channel |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Nexstim Oyj Registered Shs Reg S, LivaNova PLC, NeuroPace Inc |
Dual channel was the largest segment with a revenue share of 57.87% in 2023. Horizon Databook has segmented the Colombia deep brain stimulation devices market based on single channel, dual channel covering the revenue growth of each sub-segment from 2018 to 2030.
Less adoption of advanced healthcare facilities and declining healthcare expenditure by the government are major factors restraining the market growth in Colombia. In addition, lack of adequate number of hospitals & clinics in the country is a major factor restraining the market growth.
Such scenario restricts key players from entering the Colombian market as the scope for growth is significantly low. Furthermore, lack of skilled professionals and proper knowledge regarding technologically advanced products is a major drawback impeding the market growth.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account